Table 1 Baseline demographics and clinical characteristics of patients (n = 90)a
Subtypes | Age (years) P-value < 0.01b | Females (%) P-value < 0.05b | Disease activity (%) | ||
|---|---|---|---|---|---|
Active | Inactive | Unknown | |||
Control (n = 18) | 6.5 (4.5–8.6) | 50% (9) | NA | NA | NA |
oJIA (n = 19) | 10.5 (4.6–14.8) | 53% (9) | 53% (10) | 16% (3) | 31% (6) |
RF-pJIA (n = 17) | 9.6 (3.8–13.8) | 50% (9) | 76% (13) | 6% (1) | 18% (3) |
RF + pJIA (n = 14) | 13.7 (5.6–17.3) | 100% (14) | 64% (9) | 7% (1) | 29% (4) |
sJIA (n = 22) | 10.8 (1.8–17.8) | 64% (14) | 50% (11) | 37% (8) | 13% (3) |